img

Global Complex Regional Pain Syndrome Treatment Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Complex Regional Pain Syndrome Treatment Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Complex Regional Pain Syndrome Treatment market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.

This report studies the Complex Regional Pain Syndrome Treatment market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Complex Regional Pain Syndrome Treatment in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
T-121
NTRX-07
Neridronic Acid
Others

Market Snapshot, By Application
Hospital
Clinic
Others

Main Market Players Analyzed in this report, including
Mallinckrodt Plc
Grunenthal GmbH
Axsome Therapeutics, Inc.
Abiogen Pharma SpA

The study objectives of this report are
To study and analyze the global Complex Regional Pain Syndrome Treatment market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Complex Regional Pain Syndrome Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Complex Regional Pain Syndrome Treatment manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Complex Regional Pain Syndrome Treatment market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Complex Regional Pain Syndrome Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Complex Regional Pain Syndrome Treatment are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Complex Regional Pain Syndrome Treatment Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Complex Regional Pain Syndrome Treatment Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Complex Regional Pain Syndrome Treatment

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Hospital
3.2.2 Major Buyers in Clinic

4 Market Segment: by Type
4.1 Complex Regional Pain Syndrome Treatment Type Introduction
4.1.1 T-121
4.1.2 NTRX-07
4.1.3 Neridronic Acid
4.1.4 Others
4.2 Global Complex Regional Pain Syndrome Treatment Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Complex Regional Pain Syndrome Treatment Type Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Complex Regional Pain Syndrome Treatment Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Complex Regional Pain Syndrome Treatment Market by Region
6.2 North America Complex Regional Pain Syndrome Treatment Market 2016-2021
6.3 Europe Complex Regional Pain Syndrome Treatment Market 2016-2021
6.4 Asia Pacific Complex Regional Pain Syndrome Treatment Market 2016-2021
6.5 South America Complex Regional Pain Syndrome Treatment Market 2016-2021
6.6 Middle East and Africa Complex Regional Pain Syndrome Treatment Market 2016-2021

7 North America
7.1 North America Complex Regional Pain Syndrome Treatment Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Complex Regional Pain Syndrome Treatment Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Complex Regional Pain Syndrome Treatment Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Complex Regional Pain Syndrome Treatment Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Complex Regional Pain Syndrome Treatment Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Mallinckrodt Plc
12.1.1 Mallinckrodt Plc Company Information
12.1.2 Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
12.1.3 Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
12.1.4 Mallinckrodt Plc Key Development
12.2 Grunenthal GmbH
12.2.1 Grunenthal GmbH Company Information
12.2.2 Grunenthal GmbH Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
12.2.3 Grunenthal GmbH Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
12.2.4 Grunenthal GmbH Key Development
12.3 Axsome Therapeutics, Inc.
12.3.1 Axsome Therapeutics, Inc. Company Information
12.3.2 Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
12.3.3 Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
12.3.4 Axsome Therapeutics, Inc. Key Development
12.4 Abiogen Pharma SpA
12.4.1 Abiogen Pharma SpA Company Information
12.4.2 Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
12.4.3 Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
12.4.4 Abiogen Pharma SpA Key Development

13 Global Complex Regional Pain Syndrome Treatment Market Forecast by Region by Type and by Application
13.1 Global Complex Regional Pain Syndrome Treatment Revenue Forecast 2022-2027
13.2 Global Complex Regional Pain Syndrome Treatment Forecast by Regions
13.3 Global Complex Regional Pain Syndrome Treatment Forecast by Type
13.4 Global Complex Regional Pain Syndrome Treatment Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Complex Regional Pain Syndrome Treatment Production Specifications
Table 2: Drivers in Complex Regional Pain Syndrome Treatment Market
Table 3: Restraints Complex Regional Pain Syndrome Treatment Market
Table 4: Opportunity in Complex Regional Pain Syndrome Treatment Market
Table 5: Comparion of Alternative and Complex Regional Pain Syndrome Treatment
Table 6: Complex Regional Pain Syndrome Treatment Raw Materials Key Suppliers List
Table 7: Complex Regional Pain Syndrome Treatment Distributors List
Table 8: Complex Regional Pain Syndrome Treatment Major Buyers in Application One
Table 9: Complex Regional Pain Syndrome Treatment Major Buyers in Application Two
Table 10: Complex Regional Pain Syndrome Treatment Major Buyers in Application Three
Table 11: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Type 2016-2021
Table 12: Global Complex Regional Pain Syndrome Treatment Revenue Market Share by Type 2016-2021
Table 18: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Application 2016-2021
Table 19: Global Complex Regional Pain Syndrome Treatment Revenue Market Share by Application 2016-2021
Table 20: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Region 2016-2021
Table 21: Global Complex Regional Pain Syndrome Treatment Revenue Market Share by Region 2016-2021
Table 22: North America Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Country 2016-2021
Table 23: North America Complex Regional Pain Syndrome Treatment Revenue Market Share by Country 2016-2021)
Table 24: Europe Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Country 2016-2021
Table 25: Europe Complex Regional Pain Syndrome Treatment Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Complex Regional Pain Syndrome Treatment Revenue Market Share by Country 2016-2021)
Table 28: South America Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Country 2016-2021
Table 29: South America Complex Regional Pain Syndrome Treatment Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Complex Regional Pain Syndrome Treatment Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Complex Regional Pain Syndrome Treatment Revenue Market Share by Country 2016-2021)
Table 32 Mallinckrodt Plc Company Information
Table 33 Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
Table 34 Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
Table 35 Grunenthal GmbH Company Information
Table 36 Grunenthal GmbH Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
Table 37 Grunenthal GmbH Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
Table 38 Axsome Therapeutics, Inc. Company Information
Table 39 Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
Table 40 Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
Table 41 Abiogen Pharma SpA Company Information
Table 42 Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Product Portfolio, Specification and Application
Table 43 Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Revenue and Gross Margin (2019-2021)
Table 59: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Complex Regional Pain Syndrome Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Complex Regional Pain Syndrome Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Complex Regional Pain Syndrome Treatment Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Complex Regional Pain Syndrome Treatment Picture
Figure 2: Global Complex Regional Pain Syndrome Treatment Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Complex Regional Pain Syndrome Treatment Industry Life Cycle
Figure 5: Product Picture of T-121
Figure 6: Product Picture of NTRX-07
Figure 9: Global Complex Regional Pain Syndrome Treatment Revenue Market Share by Type, 2020
Figure 10: Complex Regional Pain Syndrome Treatment in Hospital
Figure 11: Global Complex Regional Pain Syndrome Treatment Market: Hospital 2016-2021
Figure 12: Complex Regional Pain Syndrome Treatment in Clinic
Figure 13: Global Complex Regional Pain Syndrome Treatment Market: Clinic 2016-2021
Figure 14: Global Complex Regional Pain Syndrome Treatment Revenue Market Share by Application, 2020
Figure 15: Global Complex Regional Pain Syndrome Treatment Revenue Market Share by Region 2016-2021
Figure 16: North America Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 7: Europe Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 8: Asia Pacific Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 9: South America Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 10: Middle East and Africa Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 11: North America Complex Regional Pain Syndrome Treatment Revenue Market Share by Country, 2020
Figure 12: United States Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 13: Canada Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 14: Mexico Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 15: Europe Complex Regional Pain Syndrome Treatment Revenue Market Share by Country, 2020
Figure 16: Germany Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 17: France Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 18: UK Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 19: Italy Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 20: Russia Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 21: Spain Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Complex Regional Pain Syndrome Treatment Revenue Market Share by Country, 2020
Figure 23: China Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 24: Japan Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 25: Korea Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 26: Southeast Asia Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 27: India Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 28: Australia Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 29: South America Complex Regional Pain Syndrome Treatment Revenue Market Share by Country, 2020
Figure 30: Brazil Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 31: Argentina Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 32: Colombia Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 33: Middle East and Africa Complex Regional Pain Syndrome Treatment Revenue Market Share by Country, 2020
Figure 34: Turkey Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 35: Saudi Arabia Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 36: South Africa Complex Regional Pain Syndrome Treatment Revenue (Million USD) Status 2016-2021
Figure 37: Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Revenue Market Share Globally (2019-2021)
Figure 38: Grunenthal GmbH Complex Regional Pain Syndrome Treatment Revenue Market Share Globally (2019-2021)
Figure 39: Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Revenue Market Share Globally (2019-2021)
Figure 40: Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Revenue Market Share Globally (2019-2021)
Figure 47: Global Complex Regional Pain Syndrome Treatment Revenue (Million USD) Forecast (2022-2027)